Cellectar Biosciences Inc (CLRB.OQ)
CLRB.OQ on NASDAQ Stock Exchange Capital Market
2.31USD
22 Mar 2019
2.31USD
22 Mar 2019
Change (% chg)
$-0.15 (-6.10%)
$-0.15 (-6.10%)
Prev Close
$2.46
$2.46
Open
$2.44
$2.44
Day's High
$2.46
$2.46
Day's Low
$2.26
$2.26
Volume
23,980
23,980
Avg. Vol
30,302
30,302
52-wk High
$12.90
$12.90
52-wk Low
$1.22
$1.22
About
Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)
Overall
| Beta: | 1.02 |
| Market Cap(Mil.): | $23.88 |
| Shares Outstanding(Mil.): | 13.92 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CLRB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 29.30 | 32.54 |
| EPS (TTM): | -1.24 | -- | -- |
| ROI: | -103.68 | 14.23 | 13.82 |
| ROE: | -105.20 | 15.46 | 15.25 |
Estimates